Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Mariane de Montalembert, Frédéric Galactéros, Lena Oevermann, Giovanna Cannas, Laure Joseph, Gylna Loko, Narcisse Elenga, Malika Benkerrou, Maryse Etienne-Julan, Marie-Pierre Castex, Regine Grosse, Valentine Brousse

Blood (2022) 140 (Supplement 1): 449–450.

https://doi.org/10.1182/blood-2022-165946

Published: 2022

Journal Articles

A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia

Blood (2022) 139 (17): 2642–2652.

https://doi.org/10.1182/blood.2021013674

Published: 2022

Includes: Supplemental data

Journal Articles

Benefits of a Disease Management Program for SCD in Germany 2011 - 2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome

Joachim B. Kunz, Andreas Schlotmann, Andrea Daubenbüchel, Stephan Lobitz, Andrea Jarisch, Regine Grosse, Holger Cario, Lena Oevermann, Dani Hakimeh, Laura Tagliaferri, Andreas E. Kulozik

Blood (2021) 138 (Supplement 1): 973.

https://doi.org/10.1182/blood-2021-148550

Published: 2021

Journal Articles

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Blood (2019) 134 (Supplement_1): 615.

https://doi.org/10.1182/blood-2019-123355

Published: 2019

Journal Articles

Diamond-Blackfan Anemia Phenotype Caused By Deficiency of Adenosine Deaminase 2

Blood (2017) 130 (Supplement 1): 874.

https://doi.org/10.1182/blood.V130.Suppl_1.874.874

Published: 2017

Journal Articles

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

Frédéric Galactéros, MDPhD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD, Corinne Pondarré, MD PhD, Jean Benoît Arlet, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Lena Oevermann, MD, Stephan Lobitz, MD

Blood (2017) 130 (Supplement 1): 3543.

https://doi.org/10.1182/blood.V130.Suppl_1.3543.3543

Published: 2017

Journal Articles

Assessment of Hematological Data in a Cohort of European Children with Sickle Cell Anemia Treated with Hydroxyurea: Can European Centers Apply Today the Lessons from the Twitch Study?

Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Regine Grosse, MD, Uwe Kordes, MD MRCP, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Corinne Armari-alla, MD, Narcisse Elenga, MD, Marcin Wlodarski, MD, Stephan Lobitz, MD

Blood (2016) 128 (22): 2494.

https://doi.org/10.1182/blood.V128.22.2494.2494

Published: 2016

Journal Articles

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Ersi Voskaridou, MD, Stephan Lobitz, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD PhD, Frederic Galacteros, MD PhD

Blood (2016) 128 (22): 2497.

https://doi.org/10.1182/blood.V128.22.2497.2497

Published: 2016

Journal Articles

Treatment of Iron Overload in Transfusion-Dependent Anemias Post Hematopoietic Stem Cell Transplantation: When to Start? When to Stop?

Andrea Jarisch, MD, Regine Grosse, MD, Emilia Salzmann-Manrique, Roland Fischer, PhD, Jan Soerensen, MD, Renate Hammerstingl, MD, Eva Rettinger, MD, Andre Manfred Willasch, MD, Thomas Klingebiel, MD, Peter Bader, MD

Blood (2015) 126 (23): 3369.

https://doi.org/10.1182/blood.V126.23.3369.3369

Published: 2015

Journal Articles

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Regine Grosse, MD, Suzan Acar, Bjoern Schoennagel, MD, Roland Fischer, PhD, Jin Yamamura, MD, Gritta Janka, MD PhD, Peter Nielsen, MD

Blood (2015) 126 (23): 3358.

https://doi.org/10.1182/blood.V126.23.3358.3358

Published: 2015

Journal Articles

The Prevalence of Hereditary Hemoglobin Disorders and Its Implications for Newborn Screening in Germany

Regine Grosse, MD, Reinhard Schneppenheim, MD PhD, Zoltan Lukacs, PhD, Florian Oyen, Birgit Muntau, Paulina Lukacs, PhD, Bernd Noack, MD

Blood (2014) 124 (21): 4071.

https://doi.org/10.1182/blood.V124.21.4071.4071

Published: 2014

Journal Articles

Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study)

John Porter, MD, Patrick B Walter, PhD, Lynne D Neumayr, MD, Patricia Evans, PhD, Marcela G Weyhmiller, PhD, Paul Harmatz, MD, John C. Wood, MD, PhD, Jeffery L Miller, MD, Guenter Weiss, MD, Quing Yuan, PhD, Zhiyue J Wang, PhD, Regine Grosse, MD, Bjoern P Schoennagel, MD, Joerg Meerpohl, MD, Roland Fischer, PhD, Peter Nielsen, MD, Markus Seifert, BSc, Elliott Vichinsky, MD

Blood (2013) 122 (21): 1014.

https://doi.org/10.1182/blood.V122.21.1014.1014

Published: 2013

Journal Articles

Pancreatic Iron and Fat Infiltration Are Diabetogenic Risk Factors In Patients With Iron Overload

Regine Grosse, MD, Charlotte Pfeiffer, Bjoern P Schoennagel, MD, Gritta E. Janka, MD, PhD, Peter Nielsen, MD, Roland Fischer, PhD, Jin Yamamura, MD

Blood (2013) 122 (21): 2204.

https://doi.org/10.1182/blood.V122.21.2204.2204

Published: 2013

Journal Articles

Iron Trafficking and Distribution in Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia

John B. Porter, MD, Patrick B Walter, PhD, Lynne D Neumayr, MD, Patricia Evans, PhD, Marcela G Weyhmiller, PhD, Paul Harmatz, MD, John C Wood, MD, Ph.D, Jeffery L. Miller, Guenter Weiss, MD, Qing Yuan, Zhiyue J Wang, Regine Grosse, MD, Bjoern P Schoennagel, Joerg Meerpohl, Roland Fischer, PhD, Elliott Vichinsky, MD

Blood (2012) 120 (21): 995.

https://doi.org/10.1182/blood.V120.21.995.995

Published: 2012

Journal Articles

Genetic Heterogeneity of Alpha - and Beta - Globin Mutations in a German Multiethnic Population Group

Regine Grosse, MD, Florian Oyen, Belinda Weber, Reinhard Schneppenheim, MD, PhD

Blood (2012) 120 (21): 5185.

https://doi.org/10.1182/blood.V120.21.5185.5185

Published: 2012

Journal Articles

Measurement of Liver Iron Concentration by Quantum Interference Device Biosusceptometry (SQUID) Validates Serum Ferritin As Prognostic Parameter for Allogeneic Stem Cell Transplantation

Nicole Jacobi, MD, MS, Regine Grosse, MD, Tugce Aktas, Lena Herich, Peter Nielsen, MD, Roland Fischer, PhD, Tatjana Zabelina, Ulrike Bacher, MD, Nicolaus Kroeger, Sr., MD

Blood (2011) 118 (21): 1018.

https://doi.org/10.1182/blood.V118.21.1018.1018

Published: 2011

Journal Articles

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Regine Grosse, MD, Andrea Jarisch, PhD, MD, Jin Yamamura, MD, Peter Nielsen, MD, Roland Fischer, PhD, Gritta Janka, MD, PhD

Blood (2011) 118 (21): 2110.

https://doi.org/10.1182/blood.V118.21.2110.2110

Published: 2011

Journal Articles

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Regine Grosse, Gritta Janka, MD, PhD, Andrea Jarisch, PhD, MD, Peter Nielsen, Jin Yamamura, Roland Fischer, PhD

Blood (2010) 116 (21): 5168.

https://doi.org/10.1182/blood.V116.21.5168.5168

Published: 2010

Journal Articles

Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.

Regine Grosse, MD, Isolde Frieling, MD, Ellen B. Fung, PhD, Achim Wuesthof, MD, Hans P. Kruse, MD, Roland Fischer, PhD, Gritta E. Janka, MD

Blood (2007) 110 (11): 2772.

https://doi.org/10.1182/blood.V110.11.2772.2772

Published: 2007

Journal Articles

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Roland Fischer, PhD, Regine Grosse, Rainer Engelhardt, PhD, Peter Nielsen, PhD, MD, Oliver Leismann, PhD, Gritta E. Janka, MD

Blood (2007) 110 (11): 2776.

https://doi.org/10.1182/blood.V110.11.2776.2776

Published: 2007

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia

Benefits of a Disease Management Program for SCD in Germany 2011 - 2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome

Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia

Diamond-Blackfan Anemia Phenotype Caused By Deficiency of Adenosine Deaminase 2

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

Assessment of Hematological Data in a Cohort of European Children with Sickle Cell Anemia Treated with Hydroxyurea: Can European Centers Apply Today the Lessons from the Twitch Study?

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Treatment of Iron Overload in Transfusion-Dependent Anemias Post Hematopoietic Stem Cell Transplantation: When to Start? When to Stop?

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

The Prevalence of Hereditary Hemoglobin Disorders and Its Implications for Newborn Screening in Germany

Inflammatory and Vitamin Bio-Markers Of Iron Trafficking and Distribution In Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia With Sickle Cell Disease and Thalassemia (MCSIO PILOT Study)

Pancreatic Iron and Fat Infiltration Are Diabetogenic Risk Factors In Patients With Iron Overload

Iron Trafficking and Distribution in Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia

Genetic Heterogeneity of Alpha - and Beta - Globin Mutations in a German Multiethnic Population Group

Measurement of Liver Iron Concentration by Quantum Interference Device Biosusceptometry (SQUID) Validates Serum Ferritin As Prognostic Parameter for Allogeneic Stem Cell Transplantation

Optimizing Iron Chelator Treatment in Cardiac and Hepatic Siderosis: Efficacy of Divided Deferasirox (EXJADE R ) – Doses

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Bone Microarchitecture Parameter for Early Diagnosis of Osteopenia in Thalassemia.

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only